IceCure Medical, Ltd. (ICCM) - נכסים מצרפיים של הפעילות העסקית

The market trend for IceCure Medical (ICCM) shown on this price chart reflects the dynamics of total assets, which currently stand at 14.15. IceCure Medical Ltd minimizes surgical risks by freezing neoplasms in the kidneys and breasts. Business growth is driven by the expansion of ProSense systems as a minimally invasive therapy method. Strict FDA regulations and exclusive cryodestruction patents ensure a high barrier to entry.

IceCure Medical Ltd (ICCM) management's drive toward international expansion and equipment certification is reflected in the trends of consolidated assets, demonstrating a resource base for scaling. This metric, reverse-calculated via ROA, aggregates the value of all controlled resources funded by equity and debt, allowing investors to assess operational scale and the risk of inefficient capital allocation.